EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Discontinuation of Additional Risk Minimisation Measure Tools Implemented at Authorisation for Centrally Authorised Medicinal Products in the EU

Sharon C M Essink, Inge M Zomerdijk, Valerie Strassmann, Thomas Goedecke, Sabine M J M Straus, Helga Gardarsdottir, Marie L De Bruin

Drug Safety · 15.11.2026

DOI: 10.1007/s40264-026-01749-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Safety, online erschienen am 15.11.2026. Verfasst von Sharon C M Essink und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlan…. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: College ter Beoordeling van Geneesmiddelen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.
  • Department of Pharmacovigilance, Medicines Evaluation Board, Utrecht, The Netherlands.
  • European Medicines Agency, Amsterdam, The Netherlands.
  • Department of Clinical Pharmacy, University Medical Centre Utrecht, Utrecht, The Netherlands.
  • Faculty of Pharmaceutical Sciences, University of Iceland, Reykjavik, Iceland.
  • Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. m.l.debruin@uu.nl.

Förderung

  • College ter Beoordeling van Geneesmiddelen

Zitieren

APA

Essink, S. C. M., Zomerdijk, I. M., Strassmann, V., Goedecke, T., Straus, S. M. J. M., Gardarsdottir, H., & De Bruin, M. L. (2026). Discontinuation of Additional Risk Minimisation Measure Tools Implemented at Authorisation for Centrally Authorised Medicinal Products in the EU. Drug Safety. https://doi.org/10.1007/s40264-026-01749-4

Vancouver

Essink SCM, Zomerdijk IM, Strassmann V, Goedecke T, Straus SMJM, Gardarsdottir H, et al. Discontinuation of Additional Risk Minimisation Measure Tools Implemented at Authorisation for Centrally Authorised Medicinal Products in the EU. Drug Safety. 2026. doi:10.1007/s40264-026-01749-4

BibTeX
@article{Essink2026,
  author = {Essink, Sharon C M and Zomerdijk, Inge M and Strassmann, Valerie and Goedecke, Thomas and Straus, Sabine M J M and Gardarsdottir, Helga and De Bruin, Marie L},
  title = {Discontinuation of Additional Risk Minimisation Measure Tools Implemented at Authorisation for Centrally Authorised Medicinal Products in the EU},
  journal = {Drug Safety},
  year = {2026},
  doi = {10.1007/s40264-026-01749-4}
}
Kostenlos starten →